Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy

Last updated: July 27, 2024
Sponsor: Sohag University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetic Neuropathy

Treatment

N/A

Clinical Study ID

NCT06514846
Soh-Med-24-06-01MS
  • Ages 33-65
  • All Genders

Study Summary

The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ü Age: 30-55 y

ü Type of diabetes: Type 2

ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria

Exclusion

Exclusion Criteria:

  • Patients who had known conditions that could present with neuropathy such ashereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplasticconditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.

Study Design

Total Participants: 100
Study Start date:
June 01, 2023
Estimated Completion Date:
June 01, 2025

Connect with a study center

  • Faculty of medecine Sohag university

    Sohag,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.